[FULC] QoQ Quarter Result on 30-Sep-2022 [#Q2]

Stock
[FULC] Fulcrum Therapeutics, Inc.
Announcement Date
08-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q2]
Profit Trend
QoQ- 29.41%
YoY- -16.10%
Quarter Report
FULC's Result
FULC's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 880 295 685 1,183 1,882 2,592 5,058 -68.93%
PBT -23,783 -24,779 -26,135 -23,738 -34,070 -25,928 -23,484 0.84%
Tax 525 -3,161 -2,505 313 -24 -70 -621 -
NP -23,783 -21,618 -23,630 -24,051 -34,070 -25,858 -23,484 0.84%
Tax Rate - - - - - - - -
Total Cost 24,663 21,913 24,315 25,234 35,952 28,450 28,542 -9.30%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -2,702.61 -7,328.14 -3,449.64 -2,033.05 -1,810.31 -997.61 -464.29 224.63%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.38 -0.36 -0.45 -0.52 -0.83 -0.64 -0.58 -24.62%
EPS Diluted -0.38 -0.36 -0.45 -0.52 -0.83 -0.64 -0.58 -24.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.